Compare CIF & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIF | UG |
|---|---|---|
| Founded | 1988 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Package Goods/Cosmetics |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.7M | 30.2M |
| IPO Year | N/A | 1995 |
| Metric | CIF | UG |
|---|---|---|
| Price | $1.64 | $6.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 62.4K | 3.4K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 10.11% | 7.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $10,545,468.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.52 | $5.58 |
| 52 Week High | $1.82 | $9.88 |
| Indicator | CIF | UG |
|---|---|---|
| Relative Strength Index (RSI) | 46.75 | 57.11 |
| Support Level | N/A | $6.26 |
| Resistance Level | $1.73 | $6.78 |
| Average True Range (ATR) | 0.03 | 0.20 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 66.52 | 78.21 |
Mfs Intermediate High Income Fund is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income, but it may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment-grade corporate bonds, government securities and other securities. The portfolio includes Midstream, Financial Institutions, Energy, Cable TV, and Utilities.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.